Nonelderly patients are at risk for gastrointestinal symptoms for up to two years after Clostridium difficile infection, a study published in PLOS ONE found. The researchers retrospectively examined ...

When I took antibiotics for a sinus infection, I began feeling weak and feverish, with diarrhea. I went to the ER and learned I had Clostridioides difficile, an infection in the large intestine. The ...

To conduct the study, researchers placed C. diff spores directly onto surgical gowns in liquid for 10 seconds, 30 seconds, 1 minute, 5 minutes and 10 minutes before they were removed and discarded.

Make sure to disinfect beds properly after they are used by someone with Clostridioides difficile, or C. diff. According to a new study, staying in a bed previously used by a person with C. diff ...

Minnie Hatch, 29, from Salt Lake City, had painful stomach cramps, and other symptoms for months before finding out she had Clostridioides difficile, or C. diff. These bacteria can grow out of control ...

Clostridioides difficile/Clostridium difficile (C. diff) is a bacterial infection and is the most common cause of healthcare-associated diarrhea. C. diff has two distinct presentations, primary and ...

After suffering repeated bouts of debilitating Clostridium difficile infections, many patients significantly change their behaviors, but some precautions may do little to prevent future infections, ...

Beacon High School will reopen on Thursday, after the school was closed Wednesday for cleanup of C. diff bacteria. The Dutchess County Department of Behavioral and Community Health confirmed a case ...

The pathogen C. diff—the most common cause of health care-associated infectious diarrhea—can use a compound that kills the human gut's resident microbes to survive and grow, giving it a competitive ...

Vowst is a prescription drug that’s used in adults to help prevent Clostridioides difficile (C. diff) infection from coming back after it has been treated. Vowst comes as an oral capsule. Vowst ...

Summit Therapeutics’ troubled C. difficile medicine may have a path forward after the FDA cleared a section of trail—however, it’s going to be a steep climb. The California biotech met with the agency ...

SEATTLE – Clostridioides difficile (C. diff) is a stealthy threat. It infects more than 500,000 people in the United States each year, and kills up to 30,000. It is a leading cause of ...